The publication of results from a recent study in the New England Journal of Medicine using...
The publication of results from a recent study in the New England Journal of Medicine using Allergan's (AGN +0.5%) Botox as a treatment for overactive bladder in women looks to be a positive. Results showed that a single injection of Botox into a woman’s bladder reduces urinary incontinence as effectively as daily drugs and is actually better at resolving the problem. This opens up a new market for the drug as a first line of defense for women who struggle with frequent urinary leakage, and if approved, could generate as much as $216M in sales by 2015.
From other sites
Video at CNBC.com (Mon, 11:40AM)
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs